U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07947472) titled 'Occupational Impact and Chemotherapy-Induced Peripheral Neuropathies (CIPN)' on Nov. 12.

Brief Summary: Advances in cancer treatment have increased the number of patients living with long-term treatment-related consequences. Among these, chemotherapy-induced peripheral neuropathy (CIPN) is common and can significantly affect patients' quality of life and daily activities. Despite its impact, CIPN remains difficult to manage, and patients often receive insufficient support regarding its functional and occupational consequences.

Occupational therapy remains underutilised in oncology, despite its potential to help patients maintain or...